In pancreatic cancer, RAGE-mediated autophagy acts by reducing the phosphorylation level of mammalian target of rapamycin (mTOR) and limiting the formation of the Beclin-1/VPS34 autophagy complex. Here, AGER is linked to pancreatic neoplasm.